EOLS
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2024-06-06–present
Board Member
Evolus, Inc. (EOLS)Equibles does not estimate personal net worth.
Get an email with a short summary when Evolus, Inc. publishes a filing, an earnings call transcript or a press release.
Get EOLS alertsVikram Malik is recorded as Board Member at Evolus, Inc. (EOLS) since March 13, 2026. Evolus, Inc. reported in an 8-K filed March 13, 2026 that Vikram Malik was appointed Class II director, effective March 13, 2026. Evolus, Inc. reported in an 8-K filed March 13, 2026 that Vikram Malik resigned as Class III director, effective March 13, 2026. Evolus, Inc. reported in an 8-K filed June 11, 2024 that Vikram Malik was appointed Class III Director, effective June 6, 2024. Evolus, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Evolus, Inc. includes David Moatazedi (CFO and Board Member), Albert G. White III (Board Member), Albert White III (Board Member) and 3 others.
“The Board accepted the resignation and immediately thereafter appointed Mr. Malik to the Board and designated him as a Class II director.”
“Mr. Malik resigned as a Class III director effective immediately prior to his appointment to the Board.”
2026-03-13–present
2026-03-13–2026-03-13
2024-06-06–2026-03-13
EOLS
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2024-06-06–present